A PHASE 2, RANDOMIZED, PARTIALLY DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AMULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE ADMINISTERED IN HEALTHY TODDLERS 12 THROUGH 15 MONTHS OF AGE

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/00 → 1/1/00

Funding

  • Pfizer, Inc ( Award # ): $12,500.00